Four new chalcones from Erythrina abyssinica

Area of Science:

• Natural Products Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Erythrina abyssinica is a plant species known for its traditional medicinal uses.
• Chalcones are a class of natural products with diverse biological activities.
• Colorectal cancer remains a significant global health challenge, necessitating novel therapeutic agents.

Purpose of the Study:

• To isolate and characterize new chalcone compounds from Erythrina abyssinica stem bark.
• To evaluate the cytotoxic activity of the isolated compounds against a human colorectal cancer cell line.

Main Methods:

• Phytochemical investigation of Erythrina abyssinica stem bark.
• Structure elucidation of isolated compounds using spectroscopic analyses (e.g., NMR, MS).
• Cytotoxicity assays using the Caco2 human colorectal cancer cell line to determine IC50 values.

Main Results:

• Four new chalcones, designated abyssinones A–D (compounds 1–4), were successfully isolated and their structures determined.
• Compounds 1, 3, and 4 demonstrated moderate cytotoxic effects against Caco2 cells.
• The IC50 values for compounds 1, 3, and 4 were recorded as 13.3, 15.1, and 11.1 μM, respectively.

Conclusions:

• The study successfully identified novel chalcones from Erythrina abyssinica.
• Abyssinones A, C, and D possess cytotoxic potential against colorectal cancer cells, warranting further investigation.
• These findings contribute to the understanding of Erythrina abyssinica's chemical constituents and their potential therapeutic applications in cancer treatment.